Rare Case of Recurrent Adamantinoma of the Tibia: Limited Efficacy of Pazopanib as a Standalone Treatment

Mahmoud Elshenawy; Sarah Khaled Aldahoul; Abduljalil Mohamed El-Sibai; Alaa Hamad; Tarek Ziad Arabi; Saleha Abdul Rab; Ahmed Badran; Tariq Alzaid; Belal Nedal Sabbah; Jean Paul Atallah

doi:10.12659/AJCR.941248

15 March 2024 : Case report Saudi Arabia

Rare Case of Recurrent Adamantinoma of the Tibia: Limited Efficacy of Pazopanib as a Standalone Treatment

Unusual or unexpected effect of treatment, Rare disease

Mahmoud Elshenawy^12ADE, Sarah Khaled Aldahoul^3EF, Abduljalil Mohamed El-Sibai^3EF, Alaa Hamad^3EF, Tarek Ziad Arabi^3ADEF*, Saleha Abdul Rab^3EF, Ahmed Badran^45ADE, Tariq Alzaid^6DE, Belal Nedal Sabbah^3E, Jean Paul Atallah^4ADE

DOI: 10.12659/AJCR.941248

Am J Case Rep 2024; 25:e941248

Authors information Article notes Copyright and License information

Introduction Case Report Discussion Conclusions References:

Related articles Order reprints Share article Share by email

View HTML version

Figure 1. Destructive bone lesion noted at the distal tibial medial cortex with the “shark bite” appearance (arrow) and extending into the soft tissue with calcific focus posteriorly.

Back to the Article

Rare Case of Recurrent Adamantinoma of the Tibia: Limited Efficacy of Pazopanib as a Standalone Treatment

Your Privacy